08 December 2022: Human Study
Use of Estimated Glomerular Filtration Rate and Urine Albumin-Creatinine Ratio Based on KDIGO 2012 Guideline in a Thai Community Hospital: Prevalence of Chronic Kidney Disease and its Risk Factors
Veeravan Lekskulchai ACDEF*DOI: 10.12659/MSMBR.938176
Med Sci Monit Basic Res 2022; 28:e938176
Table 4 Patients with chronic kidney disease and end-stage kidney disease by sex.
| Male | Female | Total | |
|---|---|---|---|
| 11 683 (42.03%) | 16 117 (57.97%) | 27 800 | |
| 4200 (50.17%) | 4172 (49.83%) | 8372 | |
| 1465 (49.38%) | 1502 (50.62%) | 2967 | |
| Age: range (mean±SD) | 25–98 (68.94±12.83) | 18–100 (70.49±12.93) | 18–100 (69.73±12.91) |
| Diabetes; n (%) | 395 (44.08%) | 501 (55.92%) | 896 |
| Non-diabetes hypertension: n (%) | 461 (51.97%) | 426 (48.03%) | 887 |
| Non-diabetes non-hypertensive CVD: n (%) | 214 (52.97%) | 190 (47.03%) | 404 |
| Infection only: n (%) | 29 (40.85%) | 42 (59.15%) | 71 |
| Cancer only: n (%) | 28 (46.67%) | 32 (53.33%) | 60 |
| SLE and rheumatoid arthritis only: n (%) | 9 (33.33%) | 18 (66.67%) | 27 |
| Kidney and urinary tract disorders only: n (%) | 132 (50.00%) | 132 (50.00%) | 264 |
| Others: n (%) | 197 (55.03%) | 161 (44.97%) | 358 |
| 218 (48.77%) | 229 (51.23%) | 447 | |
| Age: range (mean±SD) | 25–88 (58.72±15.33) | 18–93 (61.22±14.46) | 18–93 (60.00±14.93) |
| Diabetes: n (%) | 37 (56.06%) | 29 (43.94%) | 66 |
| Non-diabetes hypertension: n (%) | 36 (47.37%) | 40 (52.63%) | 76 |
| Non-diabetes non-hypertensive CVD: n (%) | 25 (39.68%) | 38 (60.32%) | 63 |
| Infection only: n (%) | 19 (57.58%) | 14 (42.42%) | 33 |
| CKD stage 5 without other diagnosis: n (%) | 81 (47.65%) | 89 (52.35%) | 170 |
| Others: n (%) | 20 (51.28%) | 19 (48.72%) | 39 |
| CKD – chronic kidney disease; CVD – cardiovascular disease; eGFR – estimated glomerular filtration rate; ESKD – end-stage kidney disease; SLE – systemic lupus erythematosus. | |||